I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Long-term outcomes of thymosin-α1 and interferon α-2b combi..:
Saruc, Murat
;
Ozden, Nuri
;
Turkel, Nurten
...
Journal of Pharmaceutical Sciences. 92 (2003) 7 - p. 1386-1395 , 2003
Link:
https://doi.org/10.1002/jps.10401
RT Journal T1 <Title>Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.1002_jps.10401&Exemplar=1&LAN=DE A1 Saruc, Murat A1 Ozden, Nuri A1 Turkel, Nurten A1 Ayhan, Semin A1 Hock, Lynette M. A1 Tuzcuoglu, Isil A1 Yuceyar, Hakan PB Elsevier BV YR 2003 SN 0022-3549 JF Journal of Pharmaceutical Sciences VO 92 IS 7 SP 1386 OP 1395 LK http://dx.doi.org/https://doi.org/10.1002/jps.10401 DO https://doi.org/10.1002/jps.10401 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
